UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 35,431 Shares of AdaptHealth Corp. (NASDAQ:AHCO)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in AdaptHealth Corp. (NASDAQ:AHCO - Free Report) by 21.8% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 197,901 shares of the company's stock after buying an additional 35,431 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned approximately 0.15% of AdaptHealth worth $1,884,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also bought and sold shares of AHCO. State of Wyoming boosted its stake in AdaptHealth by 26.5% in the 4th quarter. State of Wyoming now owns 30,641 shares of the company's stock valued at $292,000 after purchasing an additional 6,418 shares during the period. ProShare Advisors LLC boosted its stake in AdaptHealth by 44.3% in the 4th quarter. ProShare Advisors LLC now owns 30,766 shares of the company's stock valued at $293,000 after purchasing an additional 9,450 shares during the period. Nuveen Asset Management LLC boosted its stake in AdaptHealth by 27.9% in the 4th quarter. Nuveen Asset Management LLC now owns 316,108 shares of the company's stock valued at $3,009,000 after purchasing an additional 69,050 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in AdaptHealth by 3.6% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 57,931 shares of the company's stock valued at $552,000 after purchasing an additional 1,999 shares during the period. Finally, Janus Henderson Group PLC boosted its stake in AdaptHealth by 42.9% in the 4th quarter. Janus Henderson Group PLC now owns 38,298 shares of the company's stock valued at $364,000 after purchasing an additional 11,500 shares during the period. Institutional investors and hedge funds own 82.67% of the company's stock.

AdaptHealth Price Performance

AHCO traded down $0.07 on Wednesday, reaching $8.75. The stock had a trading volume of 914,656 shares, compared to its average volume of 1,286,092. AdaptHealth Corp. has a fifty-two week low of $7.11 and a fifty-two week high of $11.90. The firm has a 50-day moving average of $8.69 and a 200-day moving average of $9.54. The company has a current ratio of 1.24, a quick ratio of 1.00 and a debt-to-equity ratio of 1.34. The company has a market capitalization of $1.18 billion, a price-to-earnings ratio of -5.30, a price-to-earnings-growth ratio of 1.08 and a beta of 1.64.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on AHCO. Royal Bank of Canada reduced their price target on AdaptHealth from $14.00 to $13.00 and set an "outperform" rating for the company in a research note on Thursday, May 8th. Truist Financial cut their target price on AdaptHealth from $14.00 to $13.00 and set a "buy" rating for the company in a research report on Monday, May 12th. Robert W. Baird upped their target price on AdaptHealth from $14.00 to $16.00 and gave the company an "outperform" rating in a research report on Thursday, February 27th. UBS Group cut their target price on AdaptHealth from $12.00 to $11.00 and set a "buy" rating for the company in a research report on Thursday, February 13th. Finally, Canaccord Genuity Group upped their target price on AdaptHealth from $13.00 to $14.00 and gave the company a "buy" rating in a research report on Wednesday, February 26th. Five equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company has an average rating of "Buy" and a consensus target price of $13.40.

AdaptHealth Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.